Mangoceuticals reports 1H results

• Mangoceuticals press release (NASDAQ:MGRX): MangoRx reported increased gross revenues with $377,258 in revenue for the six months ended June 30, 2024.
• Gross profit reached $217,190.

More on Mangoceuticals

• Mangoceuticals stock rallies on Japanese patent allowance
• Microcap Mangoceuticals doubles on plan to sell cheap oral GLP-1 weight loss meds
• Financial information for Mangoceuticals